Rights and permissions
About this article
Cite this article
β-Blockers underused in secondary prevention after MI. Pharmacoecon. Outcomes News 133, 10 (1997). https://doi.org/10.1007/BF03272088
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03272088